Krintafel is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Glaxosmithkline Llc. The primary component is Tafenoquine Succinate.
Product ID | 0173-0889_1ea81964-b3a3-42e1-9d3c-fbd5fed5d921 |
NDC | 0173-0889 |
Product Type | Human Prescription Drug |
Proprietary Name | Krintafel |
Generic Name | Tafenoquine Succinate |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2019-01-22 |
Marketing Category | NDA / NDA |
Application Number | NDA210795 |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | TAFENOQUINE SUCCINATE |
Active Ingredient Strength | 150 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2019-01-22 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA210795 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-01-22 |
Marketing Category | NDA |
Application Number | NDA210795 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-01-22 |
Ingredient | Strength |
---|---|
TAFENOQUINE SUCCINATE | 150 mg/1 |
SPL SET ID: | 5cf989d5-36f5-4561-a30b-9fcb9deb6b6a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
KRINTAFEL 87219174 5950504 Live/Registered |
Glaxo Group Limited 2016-10-28 |
KRINTAFEL 86076979 not registered Dead/Abandoned |
Glaxo Group Limited 2013-09-27 |
KRINTAFEL 85017408 not registered Dead/Abandoned |
Glaxo Group Limited 2010-04-19 |